Conmed

Conmed Current Assets

Current Assets of Conmed (CNMD) as of Nov 20, 2026.

Current Assets

-USD

Last updated:

Current Assets of Conmed is 2026 - USD. Current Assets of Conmed was 2025 - USD. It decreases by % lower compared to the previous year.

The Conmed Current Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Assets
Date
Current Assets
Jan 1, 1992
25.70 M USD
Jan 1, 1994
28.30 M USD
Jan 1, 1995
49.20 M USD
Jan 1, 2005
258.91 M USD
Jan 1, 2006
249.92 M USD
Jan 1, 2007
279.06 M USD
Jan 1, 2008
293.02 M USD
Jan 1, 2009
324.74 M USD
The Conmed Current Assets history
YEARCurrent AssetsYoY
324.74 MUSD+10.82%
293.02 MUSD+5.00%
279.06 MUSD+11.66%
249.92 MUSD-3.47%
258.91 MUSD+426.23%
49.20 MUSD+73.85%
28.30 MUSD+10.12%
25.70 MUSD+1.58%
25.30 MUSD+125.89%
11.20 MUSD-9.68%
12.40 MUSD+37.78%
9.00 MUSD-7.22%
9.70 MUSD+155.26%
3.80 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Conmed Stock analysis

What does Conmed do? Conmed Corporation is a leading medical technology company that offers a wide range of surgical instruments and devices for the fields of gastroenterology, endoscopy, orthopedics, gynecology, and electro surgery. The company was founded in 1970 and is headquartered in Utica, New York. The history of Conmed Corp began with the founding of Consolidated Medical Equipment, Inc. (CME) in 1970. The company initially started its business with the distribution of surgical instruments and devices for medical applications and quickly expanded in this field. In the 1980s, the company went public. In the 1990s, the company changed its name to Conmed Corporation and expanded its activities into the field of electro surgery, which has since become a major growth driver for the company. Today, Conmed Corp operates multiple manufacturing facilities worldwide and has sales offices in over 50 countries. The company is divided into four main business segments: gastroenterology, endoscopy, orthopedics, and electro surgery. The gastroenterology segment includes products for the diagnosis and treatment of gastrointestinal disorders, such as endoscopes, biopsy instruments, dilation balloons, trocars, and shears. In the endoscopy segment, Conmed Corp offers products for the diagnosis and treatment of digestive tract disorders, including endoscopes, biopsy instruments, dilation balloons, trocars, and shears. The orthopedics segment includes a wide range of surgical instruments and devices for the treatment of musculoskeletal disorders, including implants, bandages, bone plates, intramedullary nails, and others. Finally, the electro surgery segment is the fastest-growing segment of Conmed Corp and includes a wide range of devices for precision surgery, including electrocautery, electro surgery, endoscopy, and laparoscopy devices. Conmed Corp aims to develop innovative medical technologies that meet the needs of patients and healthcare professionals. The company places great emphasis on producing high-quality products that are reliable and safe. Conmed Corp is a successful company that continues to evolve and expand its product range to meet the rapidly evolving needs of the medical community. Conmed is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Conmed stock

On Eulerpool you can find the complete historical development of Current Assets Conmed since 2006 – with annual values, charts, and detailed analysis.

Current assets are assets expected to be converted to cash within one year, including cash, receivables, and inventory.

Current Assets's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Assets's Conmed historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Conmed

All Key Metrics — Conmed